When it comes to lung metastases, 72.5% are PSMA-positive in [68Ga]Ga-PSMA-11-PET/CT, while 27.5% are PSMA-negative, complicating the distinction between metastases, benign lesions, and primary lung cancer [64,65]. This evidence concerns the gene FOLH1 and lung carcinoma.